Atea Pharmaceuticals (AVIR) Return on Sales (2021 - 2022)
Atea Pharmaceuticals (AVIR) has 2 years of Return on Sales data on record, last reported at 0.19% in Q3 2022.
- For Q3 2022, Return on Sales rose 104.0% year-over-year to 0.19%; the TTM value through Sep 2022 reached 0.19%, up 3.0%, while the annual FY2021 figure was 0.34%, 57.0% up from the prior year.
- Return on Sales reached 0.19% in Q3 2022 per AVIR's latest filing, up from 0.07% in the prior quarter.
- Across five years, Return on Sales topped out at 0.61% in Q4 2021 and bottomed at 0.86% in Q3 2021.